-
ADVANCING REIMBURSEMENT CHALLENGES FOR ADVANCED THERAPY MEDICINAL PRODUCTS: A ROOT CAUSE ANALYSIS
Aug 11, 2026, 17:16 PM -
CLOSING GAPS IN REAL-WORLD EVIDENCE: UNLOCKING CLINICAL VALUE FROM UNSTRUCTURED EHR NOTES
Aug 11, 2026, 17:16 PM -
IMPACT OF US MOST-FAVOURED NATION (MFN) PRICING POLICY ON PCPA NEGOTIATION ACTIVITY IN CANADA
Aug 11, 2026, 17:16 PM -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF SPINAL MUSCULAR ATROPHY IN TURKIYE: A SCOPING REVIEW
Aug 11, 2026, 17:16 PM -
ANTIFUNGAL STEWARDSHIP IN A CENTRAL HOSPITAL: GUIDELINE ADHERENCE, CONSUMPTION AND 30-DAY MORTALITY IN 2025
Aug 11, 2026, 17:16 PM -
FAMILY SPILLOVER EFFECTS IN PHARMACOECONOMIC EVALUATION: A SYSTEMATIC REVIEW OF INTERNATIONAL GUIDELINES
Aug 11, 2026, 17:16 PM -
HOW DO HTA AGENCIES EVALUATE EXTERNAL CONTROL ARM EVIDENCE? FINDINGS FROM CAR-T APPRAISALS ACROSS FIVE JURISDICTIONS
Aug 11, 2026, 17:16 PM -
NAVIGATING THE NEW NICE HEALTHTECH PROGRAMME: PRACTICAL IMPLICATIONS AND STRATEGIC CONSIDERATIONS FOR MARKET ACCESS
Aug 11, 2026, 17:16 PM -
REAL-WORLD CLINICAL INDICATORS PRIOR TO FIRST-LINE TREATMENT INITIATION IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A NORSTELLALINQ CLAIMS AND EHR ANALYSIS
Aug 11, 2026, 17:16 PM -
IDENTIFYING CANDIDATE SURROGATE ENDPOINTS FOR OVERALL SURVIVAL IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: ESTABLISHING INDIVIDUAL-LEVEL SURROGACY
Aug 11, 2026, 17:16 PM -
INPATIENT BURDEN OF INFLUENZA AND INFLUENZA-LIKE ILLNESS AMONG ADULTS IN GERMANY, 2022-2025
Aug 11, 2026, 17:16 PM -
A REAL-WORLD PHARMACOECONOMIC EVALUATION OF CAMRELIZUMAB PLUS CHEMOTHERAPY FOR ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA UNDER THE NATIONAL REIMBURSEMENT DRUG LIST NEGOTIATION POLICY IN CHINA
Aug 11, 2026, 17:16 PM -
A MEETING WITHOUT A RECORD: THE PROCEDURAL EMPTINESS OF THE PICO CLARIFICATION MEETING IN EU JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
THE ASSOCIATION BETWEEN EVENT-FREE SURVIVAL (EFS) AND OVERALL SURVIVAL (OS) IN HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC) IN THE NETHERLANDS: AN OBSERVATIONAL STUDY OF ELECTRONIC HEALTH RECORDS
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF MODEL-INFORMED PRECISION DOSING VERSUS GUIDELINE DOSING FOR POLYMYXIN B: A SIMULATION-BASED ECONOMIC EVALUATION
Aug 11, 2026, 17:16 PM -
THE IMPACT OF BREXIT ON PHARMACEUTICAL REGULATION AND APPROVAL IN THE UK
Aug 11, 2026, 17:16 PM -
A NOVEL REGISTRY-DATABASE LINKAGE TO ENABLE REAL-WORLD EVIDENCE GENERATION IN RARE DISEASES: ALGORITHM DEVELOPMENT AND VALIDATION FOR MYOTONIC DYSTROPHY TYPE 1 IN THE FRENCH SNDS
Aug 11, 2026, 17:16 PM -
TRIMETHYLAMINE N-OXIDE AS A BIOMARKER OF ATHEROSCLEROSIS: AN EXPLORATORY STUDY IN A SOUTH INDIAN COHORT
Aug 11, 2026, 17:16 PM -
REIMBURSEMENT OF NEW ORPHAN MEDICINES IN FINLAND: A SURVIVAL ANALYSIS OF ACCESS DELAYS
Aug 11, 2026, 17:16 PM -
THE HYPOTHETICAL SCENARIO-BASED COMPARATIVE ASSESSMENT (SCAN) MODEL: EVALUATING HEALTHCARE RESOURCE UTILISATION ACROSS TREATMENT STRATEGIES FOR REFRACTORY OR UNEXPLAINED CHRONIC COUGH
Aug 11, 2026, 17:16 PM
